These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 21183907)
1. [The use of antistax in the treatment of discirculatory encephalopathy]. Rzheusskaia GV; Listopadov IuI; Kireenkov IS; Kitaeva EA; Makarova NV; Eremina NA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):60-3. PubMed ID: 21183907 [TBL] [Abstract][Full Text] [Related]
2. [Assessment of dose-dependent effect during phlebotropic therapy of chronic diseases of lower-limb veins]. Tsukanov IuT; Tsukanov AIu; Vasilevich VV Angiol Sosud Khir; 2010; 16(3):71-5. PubMed ID: 21280296 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study. Rabe E; Stücker M; Esperester A; Schäfer E; Ottillinger B Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):540-7. PubMed ID: 21239190 [TBL] [Abstract][Full Text] [Related]
4. [Pathophysiological mechanisms of lower limb chronic venous insufficiency and possibility of its correction with Antistax]. Stoĭko IuM; Gudymovich VG Angiol Sosud Khir; 2006; 12(3):77-82. PubMed ID: 17641618 [TBL] [Abstract][Full Text] [Related]
5. [Phlebopathies: aetiology and therapeutic management]. Ivanov EV Angiol Sosud Khir; 2008; 14(1):79-84. PubMed ID: 19156034 [TBL] [Abstract][Full Text] [Related]
6. [Experience in using Аntistax® in patients with lower limb chronic venous insufficiency and accompanying arterial hypertension]. Sabel'nikov VV; Sholkov SI Angiol Sosud Khir; 2013; 19(1):83-5. PubMed ID: 23531664 [TBL] [Abstract][Full Text] [Related]
7. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy]. Abramenko IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676 [TBL] [Abstract][Full Text] [Related]
8. [Clinical-neurophysiological study of efficacy of adaptol in discirculatory encephalopathy]. Barantsevich ER; Posokhina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):68-72. PubMed ID: 22027612 [TBL] [Abstract][Full Text] [Related]
9. [The role of the reactivity of cerebral vessels in the diagnosis and treatment of circulatory encephalopathies]. Burtsev EM; Molokov DD Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):8-12. PubMed ID: 2175099 [TBL] [Abstract][Full Text] [Related]
10. [Circulatory encephalopathy in patients with arterial hypertension]. Karlov VA; Kulikov IuA; Il'ina NL; Grabovskaia NV Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(5):15-7. PubMed ID: 9245151 [TBL] [Abstract][Full Text] [Related]
11. Oedema protective properties of the red vine leaf extract AS 195 (Folia vitis viniferae) in the treatment of chronic venous insufficiency. A 6-week observational clinical trial. Schaefer E; Peil H; Ambrosetti L; Petrini O Arzneimittelforschung; 2003; 53(4):243-6. PubMed ID: 12785119 [TBL] [Abstract][Full Text] [Related]
12. [Venous insufficiency: clinical features, diagnosis and treatment]. Lipko VI Lik Sprava; 2012; (7):140-3. PubMed ID: 23350134 [TBL] [Abstract][Full Text] [Related]
13. [Role of deficient cerebral circulation in selecting the treatment methods for patients with circulatory encephalopathy]. Lushchyk UB Klin Khir (1962); 1993; (9-10):26-9. PubMed ID: 7908998 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Kiesewetter H; Koscielny J; Kalus U; Vix JM; Peil H; Petrini O; van Toor BS; de Mey C Arzneimittelforschung; 2000 Feb; 50(2):109-17. PubMed ID: 10719612 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of glycine and limontar in the complex therapy of discirculatory encephalopathy and encephalopathy in diabetes mellitus type I]. Chuĭko MR; Efremova NM; Skvortsova VI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):44-8. PubMed ID: 20559273 [TBL] [Abstract][Full Text] [Related]
16. [A state of hemostasis in patients with arterial hypertension complicated with early forms of chronic cerebrovascular pathology]. Stroeva VS Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):56-60. PubMed ID: 18833119 [TBL] [Abstract][Full Text] [Related]
17. [Solcoseryl--new preparation for the pathogenetic treatment of patients with paroxysmal forms of cerebrovascular pathology]. Rudenko AIu; Bashkirova LM Lik Sprava; 2003; (7):110-3. PubMed ID: 14723151 [TBL] [Abstract][Full Text] [Related]
18. [Halidor in the treatment of cerebral vascular diseases in emergency cases]. Nevzorov NM; Razova TG; Markevich IuN Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):24-6. PubMed ID: 19156122 [TBL] [Abstract][Full Text] [Related]
19. [A new approach to the treatment of patients with circulatory encephalopathy]. Kupnovyts'ka MIu; Lushchyk UB; Herasymchuk RD; Chmyr HS; Iatsyshyn RI; Dubanovych LB Lik Sprava; 1997; (5):142-5. PubMed ID: 9491724 [TBL] [Abstract][Full Text] [Related]
20. [New approaches to neuro-metabolic pharmacotherapy of discirculatory encephalopathy]. Burchinskiĭ SG Lik Sprava; 2010; (7-8):84-90. PubMed ID: 21714293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]